Spectralink appoints new DECT Director of Engineering

Torben Laursen to spearhead newly strengthened engineering team Horsens, Denmark – 05 September, 2018 – Spectralink Corporation, the global leader in enterprise mobility solutions for the healthcare, retail, manufacturing and hospitality industries, today announced the appointment of Torben Laursen to spearhead DECT Engineering. Torben will be responsible for the full scope of DECT engineering activities including planning and execution of software development, manufacturing support, escalation support, hardware development, and technical documentation. Torben joins the company as part of a significant investment in its DECT portfolio. DECT telecommunications remains a stable…

Read More

RigNet Secures Global Master Supply Agreement

RigNet to Provide Managed Communications Services and OTT Solutions to McDermott’s Global Fleet HOUSTON, Sept. 05, 2018 (GLOBE NEWSWIRE) — RigNet’s (NASDAQ: RNET) fast-track installation and highly differentiated end-to-end connectivity helped secure a global master supply agreement with a subsidiary of McDermott International, Inc. (NYSE: MDR). A premier, fully integrated provider of technology, engineering and construction solutions to the energy industry, RigNet provided McDermott with managed communication services and multiple over-the-top (OTT) solutions to ensure their fleet of vessels is equipped with the most advanced communication systems available.  RigNet was…

Read More

Cambridge Security Seals Promotes Shannon McElroy to Vice President Operations

Leading American Manufacturer of Tamper-Evident Seals Strengthens Management Team By Elevating “Core Manager” to Senior Level Role Pomona, New York, Sept. 05, 2018 (GLOBE NEWSWIRE) — POMONA, NEW YORK, September 4, 2018   —  Cambridge Security Seals (CSS), a global leader in tamper-evident seals and security solutions, recently announced the promotion of Shannon McElroy to Vice President Operations.  McElroy has been with CSS for the past six years, rising through the ranks of the company by handling increased managerial responsibilities across multiple disciplines within the company’s Finance, Accounting, and Operations. “Shannon…

Read More

Fibrocell Announces FDA Fast Track Designation of FCX-013 for Treatment of Moderate to Severe Localized Scleroderma

EXTON, Pa., Sept. 05, 2018 (GLOBE NEWSWIRE) — Fibrocell Science, Inc. (NASDAQ:FCSC), a gene therapy company focused on transformational autologous cell-based therapies for skin and connective tissue diseases, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation to FCX-013, the Company’s clinical stage candidate for the treatment of moderate to severe localized scleroderma—a chronic, debilitating genetic skin disorder with no FDA approved therapies. “Fast Track designation represents an important milestone in advancing clinical development of FCX-013,” said John Maslowski, President and Chief Executive Officer…

Read More

Global Launch: HUBER+SUHNER bring the SENCITY® Rail Multi to market – the all-in-one antenna driving railway innovation

The antenna – now ready to purchase – will enable new wireless offerings on trains to increase passenger numbers and satisfaction Herisau, 5 September – HUBER+SUHNER, leading manufacturer of components and systems for optical and electrical connectivity, has announced the worldwide launch of the SENCITY Rail Multi. The unique roof-top antenna meets the special requirements of rail applications and enables a fully connected fleet, leading to improved customer satisfaction for Train Operating Companies (TOC’s). Designed to improve rail connectivity and drive productivity, the antenna aids the transition to a digital…

Read More

ProQR Announces Positive Interim Results from Phase 1/2 Clinical Trial of QR-110 in LCA10 Patients, and Plans to Start a Phase 2/3 Pivotal Trial

QR-110 demonstrated rapid and sustained improvement in vision in the majority of subjects, as measured by visual acuity and mobility course QR-110 was well-tolerated with no serious adverse events A Phase 2/3 pivotal trial is expected to start in the first half of 2019 Management to host a conference call today at 8:15 a.m. ET LEIDEN, Netherlands & CAMBRIDGE, Mass., Sept. 05, 2018 (GLOBE NEWSWIRE) — ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to changing lives through the creation of transformative RNA medicines for the treatment of severe genetic rare…

Read More

An Ode to Blacklane’s 300th City

BERLIN, Sept. 05, 2018 (GLOBE NEWSWIRE) — The following is an ode to celebrate Blacklane’s expansion to its 300th city around the world. There once was a chauffeur businessThat expanded with particular swiftness.To announce its new city,Blacklane got wittyAnd showed the world it’s ambitious. Today’s city is number 300.“What could it be?” people thundered.Would it be in Korea?Perhaps Tanzania?Yet because of this poem, no one wondered. Blacklane’s 300th is Irish.Our service worldwide is stylish.To end the shtick,It’s Limerick,And below is a gift you’ll cherish. Book your Blacklane chauffeur today.We’ll give…

Read More